**IPO activity in the final months of 2026 faces selective market conditions after a strong year-to-date performance.** SpaceX’s record June listing helped drive over $146 billion in global proceeds through mid-September, with 109 deals priced, though momentum has since slowed amid concerns over AI valuations, elevated Treasury yields near 19-year highs, and post-listing price volatility. Recent SEC data show robust first-half corporate issuance volumes, but several high-profile candidates including Oura, EG Group, and Holtec have postponed or withdrawn amid cautious institutional demand. Multiple S-1 and F-1 filings continue, including biotechs and data-center names, while India’s October pipeline features Jio Platforms and others exceeding ₹39,000 crore. Key near-term catalysts include potential Anthropic timing after the midterms, FOMC decisions, and year-end earnings that could influence risk appetite and pricing windows before December 31. Trader consensus on individual names reflects these dynamics, with higher implied probabilities for companies closer to filing effectiveness and lower for those facing valuation or regulatory hurdles.